Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 676

1.

Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.

Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L.

Hum Pathol. 2007 Feb;38(2):332-41. Epub 2006 Nov 28.

PMID:
17134736
2.

Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate.

Molinié V, Fromont G, Sibony M, Vieillefond A, Vassiliu V, Cochand-Priollet B, Hervé JM, Lebret T, Baglin AC.

Mod Pathol. 2004 Oct;17(10):1180-90.

3.
4.

Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.

Zhou M, Shah R, Shen R, Rubin MA.

Am J Surg Pathol. 2003 Mar;27(3):365-71.

PMID:
12604893
6.

Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.

Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA.

Am J Surg Pathol. 2002 Sep;26(9):1161-8.

PMID:
12218572
7.

Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.

Browne TJ, Hirsch MS, Brodsky G, Welch WR, Loda MF, Rubin MA.

Hum Pathol. 2004 Dec;35(12):1462-8.

PMID:
15619204
8.

Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.

Magi-Galluzzi C, Luo J, Isaacs WB, Hicks JL, de Marzo AM, Epstein JI.

Am J Surg Pathol. 2003 Aug;27(8):1128-33.

PMID:
12883245
9.

Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.

Jiang Z, Li C, Fischer A, Dresser K, Woda BA.

Am J Clin Pathol. 2005 Feb;123(2):231-6.

PMID:
15842047
11.

Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.

Boran C, Kandirali E, Yilmaz F, Serin E, Akyol M.

Urol Oncol. 2011 Nov-Dec;29(6):614-23. doi: 10.1016/j.urolonc.2009.11.013. Epub 2010 Mar 2.

PMID:
20189848
12.

[Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer].

Yu T, Zhu SX, Zheng S, Chen SP.

Zhonghua Nan Ke Xue. 2007 Mar;13(3):222-5. Chinese.

PMID:
17393784
14.

Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy.

Suzue K, Montag AG, Tretiakova M, Yang XJ, Sahoo S.

Am J Clin Pathol. 2005 Apr;123(4):553-61.

PMID:
15743746
15.
17.

Immunohistochemistry in diagnostic surgical pathology of the prostate.

Hameed O, Humphrey PA.

Semin Diagn Pathol. 2005 Feb;22(1):88-104. Review.

PMID:
16512601
18.

Variation of alpha-methylacyl-CoA racemase expression in prostate adenocarcinoma cases receiving hormonal therapy.

Tang X, Serizawa A, Tokunaga M, Yasuda M, Matsushita K, Terachi T, Osamura RY.

Hum Pathol. 2006 Sep;37(9):1186-92. Epub 2006 Jul 18.

PMID:
16938524
19.
20.

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM.

Cancer Res. 2002 Apr 15;62(8):2220-6.

Supplemental Content

Support Center